Johnson Controls International (JCI) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Jul, 2026Executive summary
Achieved 6% organic sales growth and 17% adjusted EPS growth for the full year, with Q4 adjusted EPS at $1.26 and a record backlog of ~$15B, driven by operational improvements and broad-based segment strength.
Proprietary business system leveraging 80/20, lean, digital, and AI principles is enhancing productivity and customer focus.
Leadership changes and talent development initiatives are underway to accelerate growth and productivity.
Orders grew 7% for the year, with Americas performance offsetting softness in China.
Strong free cash flow conversion at 102%, reflecting disciplined capital allocation.
Financial highlights
Q4 organic revenue grew 4% year-over-year to $6.44B; segment margin expanded to 18.8%.
Adjusted EPS for Q4 was $1.26, up 14% year-over-year; full-year adjusted EPS was $3.76, up 17%.
Full-year sales grew 6% organically to $23.6B; segment margins expanded 100 bps to 17.1%.
Adjusted free cash flow conversion reached 102% for the year, with adjusted free cash flow at $2.5B.
Orders grew 7% for the year, backlog expanded 13% to ~$15B.
Outlook and guidance
FY26 guidance: mid-single-digit organic sales growth, adjusted EPS of ~$4.55 (over 20% growth), operating leverage ~50%, and adjusted free cash flow conversion ~100%.
Q1 FY26: organic sales growth of ~3%, operating leverage ~55%, adjusted EPS ~$0.83.
Long-term targets: mid-single-digit revenue growth, 30%+ operating leverage, double-digit adjusted EPS growth, and ~100% free cash flow conversion.
Corporate expense for FY26 projected at $375M–$400M; tax rate ~17%.
Latest events from Johnson Controls International
- Q4 organic sales up 10%, margin and EPS rose; FY25 outlook strong with restructuring and growth.JCI
Q4 20248 Jul 2026 - Organizational transformation and data center growth drive efficiency, cash flow, and profitability.JCI
Bank of America Industrials, Transportation, & Airlines Key Leaders Conference 20258 Jul 2026 - Q3 delivered growth, margin expansion, record backlog, and major divestitures amid portfolio shift.JCI
Q3 20248 Jun 2026 - Q1 2025 saw 10% organic growth, 39% EPS gain, and raised full-year guidance.JCI
Q1 20258 Jun 2026 - Q2 2025 saw 7% organic sales growth, margin expansion, and raised FY25 guidance.JCI
Q2 20258 Jun 2026 - Q3 saw 6% organic sales growth, record backlog, and expanded share repurchase authorization.JCI
Q3 20258 Jun 2026 - Sales, EPS, and backlog hit records, with raised FY26 guidance and strong demand across regions.JCI
Q1 20268 Jun 2026 - Q2 saw 8% sales growth, 45% adjusted EPS growth, and record backlog, prompting raised guidance.JCI
Q2 20268 Jun 2026 - Innovation and operational excellence drive high single-digit organic growth and service expansion.JCI
Analyst Day 20265 Jun 2026